Tanya G. Weinstock

1.2k total citations · 1 hit paper
17 papers, 458 citations indexed

About

Tanya G. Weinstock is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Endocrine and Autonomic Systems. According to data from OpenAlex, Tanya G. Weinstock has authored 17 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 2 papers in Endocrine and Autonomic Systems. Recurrent topics in Tanya G. Weinstock's work include Cystic Fibrosis Research Advances (8 papers), Obstructive Sleep Apnea Research (5 papers) and Tracheal and airway disorders (3 papers). Tanya G. Weinstock is often cited by papers focused on Cystic Fibrosis Research Advances (8 papers), Obstructive Sleep Apnea Research (5 papers) and Tracheal and airway disorders (3 papers). Tanya G. Weinstock collaborates with scholars based in United States, Germany and Canada. Tanya G. Weinstock's co-authors include Susan Redline, Michael Rueschman, Faramarz Ismail‐Beigi, Xuelei Wang, Joan Aylor, Denise C. Babineau, Reena Mehra, Neil Ahluwalia, Anna Chin and Rui Wang and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal and SLEEP.

In The Last Decade

Tanya G. Weinstock

14 papers receiving 450 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele

2023 74 citations Jennifer L. Goralski, Jordana E. Hoppe et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tanya G. Weinstock United States	6	282	244	183	56	44	17	458
Maya Ramagopal United States	11	194 0.7×	114 0.5×	65 0.4×	28 0.5×	15 0.3×	24	350
José Ramón Villa-Asensi Spain	8	280 1.0×	162 0.7×	61 0.3×	18 0.3×	18 0.4×	13	428
Kiran Nandalike United States	11	178 0.6×	294 1.2×	168 0.9×	35 0.6×	33 0.8×	26	426
Sofia Konstantinopoulou United States	8	195 0.7×	223 0.9×	167 0.9×	32 0.6×	31 0.7×	14	328
Ron B. Mitchell United States	5	213 0.8×	330 1.4×	249 1.4×	28 0.5×	27 0.6×	6	374
Andreas Palm Sweden	12	188 0.7×	182 0.7×	116 0.6×	66 1.2×	37 0.8×	46	434
Josephine M. Cheung China	6	135 0.5×	301 1.2×	246 1.3×	80 1.4×	82 1.9×	7	397
Gabriel Aljadeff United States	8	109 0.4×	193 0.8×	209 1.1×	18 0.3×	59 1.3×	10	315
Mark Palayew Canada	8	173 0.6×	445 1.8×	309 1.7×	212 3.8×	120 2.7×	11	596
H.-W. Duchna Germany	9	185 0.7×	340 1.4×	232 1.3×	57 1.0×	39 0.9×	30	453

Countries citing papers authored by Tanya G. Weinstock

Since Specialization

Citations

This map shows the geographic impact of Tanya G. Weinstock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanya G. Weinstock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanya G. Weinstock more than expected).

Fields of papers citing papers by Tanya G. Weinstock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanya G. Weinstock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanya G. Weinstock. The network helps show where Tanya G. Weinstock may publish in the future.

Co-authorship network of co-authors of Tanya G. Weinstock

This figure shows the co-authorship network connecting the top 25 collaborators of Tanya G. Weinstock. A scholar is included among the top collaborators of Tanya G. Weinstock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanya G. Weinstock. Tanya G. Weinstock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Castellani, Carlo, Fredrick Van Goor, Benedetta Fabrizzi, et al.. (2026). Elexacaftor/tezacaftor/ivacaftor for cystic fibrosis and rare CFTR variants: in vitro translation to a phase 3, double-blind, randomized, placebo-controlled trial, and real-world study. American Journal of Respiratory and Critical Care Medicine. 212(2). 327–337.

Durieu, I., Barry Clements, Benedetta Fabrizzi, et al.. (2025). Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance and Abnormal Glucose Metabolism: A Phase 3b, Open-Label Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 211(10). 1926–1934. 1 indexed citations

Mall, Marcus, Claire Wainwright, Julian Legg, et al.. (2025). Elexacaftor/tezacaftor/ivacaftor in children aged ≥6 years with cystic fibrosis heterozygous for F508del and a minimal function mutation: results from a 96-week open-label extension study. European Respiratory Journal. 66(1). 2402435–2402435. 2 indexed citations

Bower, Julie K., Cherry Yin‐Yi Chang, Anna Chin, et al.. (2024). WS01.04 Real-world outcomes in people with cystic fibrosis (pwCF) treated with elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) with up to three years of follow-up. Journal of Cystic Fibrosis. 23. S2–S2. 1 indexed citations

Goralski, Jennifer L., Jordana E. Hoppe, Marcus Mall, et al.. (2023). Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele. American Journal of Respiratory and Critical Care Medicine. 208(1). 59–67. 74 indexed citations breakdown →

Wainwright, Claire, Susanna A. McColley, Paul McNally, et al.. (2023). Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged ≥6 Years with Cystic Fibrosis and at Least One F508del Allele: A Phase 3, Open-Label Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 208(1). 68–78. 34 indexed citations

Bower, Julie K., Nataliya Volkova, Neil Ahluwalia, et al.. (2023). Real-world safety and effectiveness of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis: Interim results of a long-term registry-based study. Journal of Cystic Fibrosis. 22(4). 730–737. 66 indexed citations

Ratjen, Félix, Hugo Murua Escobar, Jonathan M. Gaffin, et al.. (2021). 562: Elexacaftor/tezacaftor/ivacaftor in children aged 6 and older with cystic fibrosis and at least 1 F508del allele: Interim results from a Phase 3 open-label extension study. Journal of Cystic Fibrosis. 20. S265–S265. 1 indexed citations

Weinstock, Tanya G., et al.. (2019). No stone unturned: Nodule Net, an intervention to reduce loss to follow-up of lung nodules. Respiratory Medicine. 157. 49–51. 4 indexed citations

10.

Sehra, Shiv T., et al.. (2019). The First Appearance Deceives Many: An Unusual Case of Sarcoidosis. A1551–A1551.

11.

Weinstock, Tanya G., Colleen L. Channick, Gaëtane Michaud, et al.. (2016). Implementation of Lung Cancer Screening Programs with Low-Dose Computed Tomography in Clinical Practice. Annals of the American Thoracic Society. 13(3). 425–427. 5 indexed citations

12.

Weinstock, Tanya G., Carol L. Rosen, Carole L. Marcus, et al.. (2014). Predictors of Obstructive Sleep Apnea Severity in Adenotonsillectomy Candidates. SLEEP. 37(2). 261–269. 121 indexed citations

13.

Gleason, Kevin J., Donghoon Shin, Michael Rueschman, et al.. (2014). Challenges in Recruitment to a Randomized Controlled Study of Cardiovascular Disease Reduction in Sleep Apnea: An Analysis of Alternative Strategies. SLEEP. 37(12). 2035–2038. 14 indexed citations

14.

Richards, Christopher J., Douglas J. Hsu, Tanya G. Weinstock, & Peter Clardy. (2013). Eosinophils. An Unexpected Delivery. Annals of the American Thoracic Society. 10(4). 390–392. 3 indexed citations

15.

Weinstock, Tanya G., Xuelei Wang, Michael Rueschman, et al.. (2012). A Controlled Trial of CPAP Therapy on Metabolic Control in Individuals with Impaired Glucose Tolerance and Sleep Apnea. SLEEP. 35(5). 617–625. 128 indexed citations

16.

Weinstock, Tanya G., Carole L. Marcus, Raouf Amin, et al.. (2012). Obstructive Sleep Apnea Severity And Associated Co-Morbidities In Candidates For Adenotonsillectomy: The Childhood Adenotonsillectomy (CHAT) Study. A1055–A1055. 1 indexed citations

17.

Weinstock, Tanya G. & Susan Redline. (2012). Comparative effectiveness research in obstructive sleep apnea: bridging gaps between efficacy studies and clinical practice. Journal of Comparative Effectiveness Research. 1(1). 83–105. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact